UCKL1_HUMAN - dbPTM
UCKL1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UCKL1_HUMAN
UniProt AC Q9NWZ5
Protein Name Uridine-cytidine kinase-like 1
Gene Name UCKL1
Organism Homo sapiens (Human).
Sequence Length 548
Subcellular Localization Cytoplasm . Nucleus . EBNA3 induces isoform 1 translocation to the nucleus, whereas it does change isoform 3 location.
Protein Description May contribute to UTP accumulation needed for blast transformation and proliferation..
Protein Sequence MAAPPARADADPSPTSPPTARDTPGRQAEKSETACEDRSNAESLDRLLPPVGTGRSPRKRTTSQCKSEPPLLRTSKRTIYTAGRPPWYNEHGTQSKEAFAIGLGGGSASGKTTVARMIIEALDVPWVVLLSMDSFYKVLTEQQQEQAAHNNFNFDHPDAFDFDLIISTLKKLKQGKSVKVPIYDFTTHSRKKDWKTLYGANVIIFEGIMAFADKTLLELLDMKIFVDTDSDIRLVRRLRRDISERGRDIEGVIKQYNKFVKPSFDQYIQPTMRLADIVVPRGSGNTVAIDLIVQHVHSQLEERELSVRAALASAHQCHPLPRTLSVLKSTPQVRGMHTIIRDKETSRDEFIFYSKRLMRLLIEHALSFLPFQDCVVQTPQGQDYAGKCYAGKQITGVSILRAGETMEPALRAVCKDVRIGTILIQTNQLTGEPELHYLRLPKDISDDHVILMDCTVSTGAAAMMAVRVLLDHDVPEDKIFLLSLLMAEMGVHSVAYAFPRVRIITTAVDKRVNDLFRIIPGIGNFGDRYFGTDAVPDGSDEEEVAYTG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
13PhosphorylationARADADPSPTSPPTA
CCCCCCCCCCCCCCC
41.1630266825
15PhosphorylationADADPSPTSPPTARD
CCCCCCCCCCCCCCC
59.1930266825
16PhosphorylationDADPSPTSPPTARDT
CCCCCCCCCCCCCCC
32.0629255136
19PhosphorylationPSPTSPPTARDTPGR
CCCCCCCCCCCCCCC
37.4029255136
23PhosphorylationSPPTARDTPGRQAEK
CCCCCCCCCCCCCCC
23.3020068231
39PhosphorylationETACEDRSNAESLDR
CCCCCCCCCHHHHHH
53.3521712546
43PhosphorylationEDRSNAESLDRLLPP
CCCCCHHHHHHHCCC
32.9121712546
53PhosphorylationRLLPPVGTGRSPRKR
HHCCCCCCCCCCCCC
29.6530266825
56PhosphorylationPPVGTGRSPRKRTTS
CCCCCCCCCCCCCHH
30.3329255136
61PhosphorylationGRSPRKRTTSQCKSE
CCCCCCCCHHHCCCC
33.5625106551
62PhosphorylationRSPRKRTTSQCKSEP
CCCCCCCHHHCCCCC
22.3425106551
63PhosphorylationSPRKRTTSQCKSEPP
CCCCCCHHHCCCCCC
32.7323927012
66UbiquitinationKRTTSQCKSEPPLLR
CCCHHHCCCCCCCEE
50.66-
67PhosphorylationRTTSQCKSEPPLLRT
CCHHHCCCCCCCEEC
64.0623927012
74PhosphorylationSEPPLLRTSKRTIYT
CCCCCEECCCCEEEE
38.2726074081
75PhosphorylationEPPLLRTSKRTIYTA
CCCCEECCCCEEEEC
17.4426074081
78PhosphorylationLLRTSKRTIYTAGRP
CEECCCCEEEECCCC
23.2825404012
80PhosphorylationRTSKRTIYTAGRPPW
ECCCCEEEECCCCCC
7.0225404012
81PhosphorylationTSKRTIYTAGRPPWY
CCCCEEEECCCCCCC
20.8425404012
88PhosphorylationTAGRPPWYNEHGTQS
ECCCCCCCCCCCCCC
19.2225404012
93PhosphorylationPWYNEHGTQSKEAFA
CCCCCCCCCCCEEEE
31.4125404012
95PhosphorylationYNEHGTQSKEAFAIG
CCCCCCCCCEEEEEE
32.0925404012
107PhosphorylationAIGLGGGSASGKTTV
EEECCCCCCCCHHHH
23.6521082442
111UbiquitinationGGGSASGKTTVARMI
CCCCCCCHHHHHHHH
38.23-
179AcetylationLKQGKSVKVPIYDFT
HHCCCCEEEEEEECC
49.7625953088
179UbiquitinationLKQGKSVKVPIYDFT
HHCCCCEEEEEEECC
49.76-
196PhosphorylationSRKKDWKTLYGANVI
CCCCCHHHHHCCCEE
22.4330622161
198PhosphorylationKKDWKTLYGANVIIF
CCCHHHHHCCCEEEE
21.3030622161
215PhosphorylationIMAFADKTLLELLDM
HHHHCCHHHHHHCCC
36.80-
228PhosphorylationDMKIFVDTDSDIRLV
CCEEEECCHHHHHHH
31.91-
230PhosphorylationKIFVDTDSDIRLVRR
EEEECCHHHHHHHHH
36.71-
254UbiquitinationRDIEGVIKQYNKFVK
CCHHHHHHHHHHHHC
44.30-
261UbiquitinationKQYNKFVKPSFDQYI
HHHHHHHCCCHHHHC
37.7721906983
261 (in isoform 1)Ubiquitination-37.7721906983
261 (in isoform 2)Ubiquitination-37.7721906983
261 (in isoform 3)Ubiquitination-37.7721906983
313PhosphorylationSVRAALASAHQCHPL
HHHHHHHHHHHCCCC
27.4328555341
317S-nitrosylationALASAHQCHPLPRTL
HHHHHHHCCCCCCHH
2.2722178444
328 (in isoform 3)Ubiquitination-50.5621906983
328UbiquitinationPRTLSVLKSTPQVRG
CCHHHHHHCCCCCCC
50.5621906983
328 (in isoform 1)Ubiquitination-50.5621906983
343UbiquitinationMHTIIRDKETSRDEF
CEEEECCCCCCHHHH
53.71-
387UbiquitinationQGQDYAGKCYAGKQI
CCCCCCCCCCCCCEE
18.85-
392UbiquitinationAGKCYAGKQITGVSI
CCCCCCCCEECEEEE
30.29-
505PhosphorylationFPRVRIITTAVDKRV
CCCEEEEEHHHHHHH
13.3123403867
506PhosphorylationPRVRIITTAVDKRVN
CCEEEEEHHHHHHHH
17.8023403867
510MalonylationIITTAVDKRVNDLFR
EEEHHHHHHHHHHHH
52.2026320211
510UbiquitinationIITTAVDKRVNDLFR
EEEHHHHHHHHHHHH
52.20-
510 (in isoform 1)Ubiquitination-52.2021906983
510AcetylationIITTAVDKRVNDLFR
EEEHHHHHHHHHHHH
52.2023749302
529PhosphorylationIGNFGDRYFGTDAVP
CCCCCCCCCCCCCCC
15.8830108239
532PhosphorylationFGDRYFGTDAVPDGS
CCCCCCCCCCCCCCC
15.7530108239
539PhosphorylationTDAVPDGSDEEEVAY
CCCCCCCCCHHHHCC
49.5912199906
546PhosphorylationSDEEEVAYTG-----
CCHHHHCCCC-----
19.7130108239
547PhosphorylationDEEEVAYTG------
CHHHHCCCC------
27.0330108239

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseRNF19BQ6ZMZ0
PMID:16709802

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UCKL1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UCKL1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BCS1_HUMANBCS1Lphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UCKL1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-539, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY.

TOP